ConductScience.org, home

Paper9607110

Optimization of the human factor VIII complementary DNA expression plasmid for gene therapy of hemophilia A.

Ill CR and 6 others. Blood Coagul Fibrinolysis, 1997. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Optimization of the human factor VIII complementary DNA expression plasmid for gene therapy of hemophilia A. Papers, record 9607110. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9607110

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Optimization of the human factor VIII complementary DNA expression plasmid for gene therapy of hemophilia A.
PubMed
Journal
Blood Coagul Fibrinolysis
PubMed
Year
1997
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
0.67
iCite
Revised in PubMed
2012-11-15
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ill CRC R
2Yang CQC Q
3Bidlingmaier SMS M
4Gonzales JNJ N
5Burns DSD S
6Bartholomew RMR M
7Scuderi PP

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA, ComplementaryMajor topic
Factor VIIIMajor topic
Gene Expression RegulationMajor topic
Genetic TherapyMajor topic
Hemophilia AMajor topic
PlasmidsMajor topic
Carcinoma, Hepatocellular
Humans
Tumor Cells, Cultured

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
41511298Engineering Liver-Specific Promoters: A Comprehensive Review of Design, Mechanisms, and Clinical Applications in Gene Therapy.Cells2025https://conductscience.org/library/papers/41511298PubMed
36264632Suppression of pullulanase-induced cytotoxic T cell response with a dual promoter in GSD IIIa mice.JCI Insight2022https://conductscience.org/library/papers/36264632PubMed
26653140A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver.Elife2015https://conductscience.org/library/papers/26653140PubMed
26015962Assessment of toxicity and biodistribution of recombinant AAV8 vector-mediated immunomodulatory gene therapy in mice with Pompe disease.Mol Ther Methods Clin Dev2014https://conductscience.org/library/papers/26015962PubMed
22428010Impact of age at administration, lysosomal storage, and transgene regulatory elements on AAV2/8-mediated rat liver transduction.PLoS One2012https://conductscience.org/library/papers/22428010PubMed
21778099Inverse zonation of hepatocyte transduction with AAV vectors between mice and non-human primates.Mol Genet Metab2011https://conductscience.org/library/papers/21778099PubMed
21204705Evaluation of adeno-associated viral vectors for liver-directed gene transfer in dogs.Hum Gene Ther2011https://conductscience.org/library/papers/21204705PubMed
21119624Long-term amelioration of feline Mucopolysaccharidosis VI after AAV-mediated liver gene transfer.Mol Ther2011https://conductscience.org/library/papers/21119624PubMed
20825281Noninvasive repetitive imaging of somatostatin receptor 2 gene transfer with positron emission tomography.Hum Gene Ther2011https://conductscience.org/library/papers/20825281PubMed
19690517Immunomodulatory gene therapy prevents antibody formation and lethal hypersensitivity reactions in murine pompe disease.Mol Ther2010https://conductscience.org/library/papers/19690517PubMed
18570932Evaluation of gene promoters for liver expression by hydrodynamic gene transfer.J Surg Res2008https://conductscience.org/library/papers/18570932PubMed
17924344Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance.Am J Hum Genet2007https://conductscience.org/library/papers/17924344PubMed
16987711Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II.Mol Ther2006https://conductscience.org/library/papers/16987711PubMed
14712305Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B.Gene Ther2004https://conductscience.org/library/papers/14712305PubMed
10097136Sustained correction of bleeding disorder in hemophilia B mice by gene therapy.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10097136PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
AMBP259PubTator's text mininghttps://conductscience.org/library/genes/259

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9607110

GET https://conductscience.org/api/papers/v1/9607110/authors